Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis

Dennis Bourdette, Daniel Hartung

Research output: Contribution to journalArticle

10 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1411-1413
Number of pages3
JournalJAMA Neurology
Volume72
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Immunosuppressive Agents
Health Care Costs
Multiple Sclerosis
Glatiramer Acetate

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis. / Bourdette, Dennis; Hartung, Daniel.

In: JAMA Neurology, Vol. 72, No. 12, 01.12.2015, p. 1411-1413.

Research output: Contribution to journalArticle

@article{1eeac77dce654633b39318f8e6db466a,
title = "Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis",
author = "Dennis Bourdette and Daniel Hartung",
year = "2015",
month = "12",
day = "1",
doi = "10.1001/jamaneurol.2015.2605",
language = "English (US)",
volume = "72",
pages = "1411--1413",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis

AU - Bourdette, Dennis

AU - Hartung, Daniel

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84950237989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950237989&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2015.2605

DO - 10.1001/jamaneurol.2015.2605

M3 - Article

VL - 72

SP - 1411

EP - 1413

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 12

ER -